Abu Dhabi: Burjeel Holdings has partnered with US-based Northwell Health to launch a highly advanced Neuroscience Institute in Abu Dhabi. The institute will be housed within Burjeel Medical City (BMC), the flagship facility of Burjeel Holdings, and will offer state-of-the-art care for both adult and pediatric patients with various neurological disorders.
The collaboration between Burjeel Holdings and Northwell Health aims to facilitate the exchange of knowledge and expertise, ensuring the delivery of exceptional patient care. Dr. Souhel Najjar, a renowned neurologist and the Professor and Chairperson of the Department of Neurology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, will lead the Institute in Abu Dhabi.
As the Executive Director and Senior Vice President of the Northwell Health Neurology Service Line, Dr. Najjar brings a wealth of experience to the institute. The establishment of the ‘Dr. Najjar Neuroscience Institute’ was formalized during a ceremony at Northwell Health’s corporate headquarters in Manhattan, New York.
Northwell Health’s Neurology Service Line is recognized regionally and internationally as a destination for neurological care, committed to improving patient outcomes and driving innovation. Patients from around the world will have access to premier treatments for a wide range of neurological disorders, benefiting from the expertise of renowned experts in the field.
Burjeel Medical City, a leading quaternary care facility with 400 beds, boasts cutting-edge medical technology and a team of internationally recognized and published physicians. The Neuroscience Institute at the hospital will be supported by state-of-the-art medical equipment and a diverse team of experts certified by top global medical boards.
The establishment of the Neuroscience Institute in Abu Dhabi marks a significant milestone in advancing neurological care in the region. Through this collaboration, Burjeel Holdings and Northwell Health aim to provide world-class medical services, enhance patient outcomes, and foster innovation in the field of neuroscience.